Hostname: page-component-78c5997874-s2hrs Total loading time: 0 Render date: 2024-11-19T14:52:11.454Z Has data issue: false hasContentIssue false
  • English
  • Français

Pharmacotherapy of ADHD in Adults

Published online by Cambridge University Press:  07 November 2014

Timothy E. Wilens
Get access Rights & Permissions [Opens in a new window]

Extract

There is a complex overlap between major depressive disorder (MDD) and attention-deficit/hyperactivity disorder (ADHD). The different therapeutic options for adult ADHD mirror those used for children with ADHD. Both stimulant and nonstimulant medications are used to treat the disorder.

Type
Expert Roundtable Supplement
Information
CNS Spectrums , Volume 13 , Issue S8: Adult Attention-Deficit/Hyperactivity Disorder and the Role of Depression , May 2008 , pp. 11 - 13
Copyright
Copyright © Cambridge University Press 2008

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1.Wilens, TE.Drug therapy for adults with attention-deficit hyperactivity disorder. Drugs. 2003;63(22):2395–2411.CrossRefGoogle ScholarPubMed
2.Vetter, VL, Elia, J, Erickson, C, et al. Cardiovascular Monitoring of Children and Adolescents With Heart Disease Receiving Stimulant Drugs. A Scientific Statement From the American Heart Association Council on Cardiovascular Disease in the Young Congenital Cardiac Defects Committee and the Council on Cardiovascular Nursing. Circulation. 2008. Epub ahead of print.CrossRefGoogle Scholar
3.Spencer, TJ, Adler, LA, McGough, JJ, et al. Efficacy and safety of dexmethylphenidate extended-release capsules in adults with attention-deficit/hyperactivity disorder. Biol Psychiatry. 2007;61(12):1380–1387.CrossRefGoogle ScholarPubMed
4.Biederman, J, Mick, E, Surman, C, et al. A randomized, placebo-controlled trial of OROS methylphenidate in adults with attention-deficit/hyperactivity disorder. Biol Psychiatry. 2006;59(9):829–835.CrossRefGoogle ScholarPubMed
5.Weisler, RH, Biederman, J, Spencer, TJ, et al. Mixed amphetamine salts extended-release in the treatment of adult ADHD: a randomized, controlled trial. CNS Spectr. 2006:11(8):625–639.Google Scholar
6.Biederman, J, Mick, E, Spencer, T, et al. An open-label trial of OROS methylphenidate in adults with late-onset ADHD. CNS Spectr. 2006;11(5):390–396.CrossRefGoogle ScholarPubMed
7.Adler, LA, Sutton, VK, Moore, RJ, et al. Quality of life assessment in adult patients with attention-deficit/hyperactivity disorder treated with atomoxetine. J Clin Psychopharmacol. 2006;26(6):648–652.CrossRefGoogle ScholarPubMed
8.Wilens, TE, Haight, BR, Horrigan, JP, et al. Bupropion XL in adults with attention-deficit/hyperactivity disorder: a randomized, placebo-controlled study. Biol Psychiatry. 2005;57(7):793–801.CrossRefGoogle ScholarPubMed
9.Biederman, J, Swanson, JM, Wigal, SB, et al. Efficacy and safety of modafinil film-coated tablets in children and adolescents with attention-deficit/hyperactivity disorder: results of a randomized, doubleblind, placebo-controlled, flexible-dose study. Pediatrics. 2005;116(6):777–784.CrossRefGoogle ScholarPubMed
10.Biederman, J, Krishnan, S, Zhang, Y, Findling, R. Efficacy and safety of lisdexamfetamine dimesylate in non-caucasian children aged 6 to 12 years with ADHD: a secondary analysis. In: Program and abstracts of the APA meeting; May 19–24, 2007; San Diego. Abstract NR 749.Google Scholar